Skip to main content

ORIGINAL RESEARCH article

Front. Vet. Sci.

Sec. Comparative and Clinical Medicine

Volume 12 - 2025 | doi: 10.3389/fvets.2025.1490369

Redox status of biomarkers in serum of dogs with hypothyroidism and its treatment with levothyroxine sodium

Provisionally accepted
Ling Zhu Ling Zhu 1Jinge Han Jinge Han 2Halihaxi Bahetijiang Halihaxi Bahetijiang 1Gang Liu Gang Liu 1John P Kastelic John P Kastelic 3Xueying Zhou Xueying Zhou 1*Bo Han Bo Han 1*
  • 1 China Agricultural University, Beijing, China
  • 2 Tianjin Agricultural University, Tianjin, Tianjin Municipality, China
  • 3 University of Calgary, Calgary, Alberta, Canada

The final, formatted version of the article will be published soon.

    Information regarding canine hypothyroidism in China remains limited and redox status in dogs with hypothyroidism is unclear in China. Therefore, the objective of this study was to evaluate the redox status of dogs with hypothyroidism and how it changed after levothyroxine replacement therapy. Ten healthy dogs and 10 dogs with hypothyroidism (control and treatment groups, respectively) from China Agricultural University Veterinary Teaching Hospital were used. Redox status was determined in all 20 dogs. Thyroid profiles thyroxine (T4), free thyroxine (fT4) and thyroid stimulating hormone (TSH) and biomarkers of oxidative stress including superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-px) and malondialdehyde (MDA) were assessed on day 0 in all dogs and on days 14 and 45 post-levothyroxine sodium treatment in dogs with hypothyroidism. Dogs with hypothyroidism had decreased serum T4 and fT4 concentrations and increased serum TSH concentrations. Based on SOD, CAT, GSH-px, and MDA, dogs with hypothyroidism had oxidative stress. However, following treatment with levothyroxine sodium (0.02 mg/kg orally twice a day for 45 days), antioxidant status was improved, with increases in SOD (60.2 to 76.7 U/mL), CAT (105.9 to 115.5 mU/mL) and GSH-px (from 10.2 to 8.4 U/mL), plus a decrease in MDA from 8.2 to 6.8 μmol on days 0 and 14, respectively, and on day 45, subsequent increases to 83.3, 132.9, and 9.7 U/mL, plus a decrease in MDA to 4.4 μmol. In conclusion: Increased serum TSH and MDA concentrations, plus decreases in serum T4 and fT4 concentrations and decreases in SOD and CAT activities indicated there was oxidative stress in dogs with hypothyroidism. However, there were significant improvements in the redox status of biomarkers in serum of dogs with hypothyroidism after treatment with levothyroxine sodium (0.02 mg/kg twice daily) for 45 days.

    Keywords: Canine hypothyroidism, Antioxidant status, Thyroxin, Thyroid stimulating hormone, levothyroxine sodium therapy

    Received: 03 Sep 2024; Accepted: 05 Mar 2025.

    Copyright: © 2025 Zhu, Han, Bahetijiang, Liu, Kastelic, Zhou and Han. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Xueying Zhou, China Agricultural University, Beijing, China
    Bo Han, China Agricultural University, Beijing, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more